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ABSTRACT 
Many studies have demonstrated disparities in awareness of and knowledge about human 
papillomavirus (HPV) among young, immigrant, and minority populations. Yet, there is a lack of 
existing research that has investigated the role of race/ethnicity and HPV screening, and how it 
varies by age. The purpose of this study was to evaluate this association using 2016 Behavioral 
Risk Factor Surveillance System (BRFSS) data. This study included 120,646 women who self-
reported information on race/ethnicity, HPV screening, and age. Logistic regression was used to 
obtain odds ratios (OR) and 95% confidence intervals (CIs). A stratified analysis was conducted 
to determine if age modified the race/ethnicity and HPV screening association. After adjustment, 
non-Hispanic Black and Multiracial women had statistically significant increased odds of 
receiving HPV screening as compared to non-Hispanic white women (OR 1.20; 95% CI 1.11, 1.29 
and OR 1.58; 95% CI 1.33, 1.88, respectively). There was no association between Hispanic 
race/ethnicity and HPV screening (OR 1.02; 95% CI 0.95, 1.09). The findings of this study provide 
evidence that age modifies the association between race/ethnicity and HPV screening. Among the 
oldest categories of women, non-Hispanic Black, Multiracial, and Hispanic women had increased 
odds of HPV screening. Conversely, among the youngest categories of women, non-Hispanic 
Other and Hispanic had decreased odds of HPV screening. Public health interventions and health 
care providers may need to focus on specific minority subgroups to increase HPV screening in 
certain sub age categories. 
Keywords:  Human Papillomavirus; HPV Screening; Race/Ethnicity; Age; Women 
 
INTRODUCTION 
Human papillomavirus (HPV) is the most common sexually transmitted infection in the 
United States (Ford, 2011). Nearly 80 million Americans are infected with at least one strain of 
HPV; however, not all types of HPV cause cancer (Blake et al., 2015). At least 12 high-risk virus 
types have been identified to cause cancer; yet, two types (HPV 16 and 18) account for 70% of all 
cervical cancer cases (Blake et al., 2015). These high-risk HPV infections may persist and increase 
the risk of developing cervical cancer, attributing to a rate of more than 12,000 new cases annually, 
with 4,000 deaths per year (Blake et al., 2015; Castellsague et al., 2009). If found early, screening 
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can prevent most cervical cancers through a preferred method called “co-testing,” a procedure that 
combines a Papanicolaou (Pap) test and HPV DNA test to detect early cervical cancers or pre-
cancers (American Cancer Society, 2016). It is recommended all women begin cervical cancer 
testing at age 21; however, a HPV test is not recommended for women aged 21-29 as the results 
are not regarded as significant as in women aged from 30-65 (American Cancer Society, 2018). 
Thus, in 2018, three updated options were recommended as screening guidelines for women aged 
30-65: (a) high-risk HPV testing alone every 5 years, (b) co-testing every 5 years, or (c) Pap testing 
alone every 3 years (American Cancer Society, 2018; National Cancer Institute, 2019). 
In 2014, Hispanic women had the highest rate of developing cervical cancer, followed by 
non-Hispanic Black and non-Hispanic White women (Centers for Disease Control and Prevention, 
2017d). Similarly, non-Hispanic Black and Hispanic women were more likely to die from cervical 
cancer than non-Hispanic White women (Blake et al., 2015). Subsequently, in 2016, cervical 
cancer incidence and mortality rates in non-Hispanic Black women were 38% and 105% higher, 
and in Hispanic women 70% and 52% higher compared to non-Hispanic White women, 
respectively (Bond et al., 2016). Thus, the relationship between race, ethnicity, and HPV screening 
becomes salient among minority populations, given cervical cancer incidence and mortality rates 
are considerably lower among non-Hispanic White women.  
Published guidelines from the American Cancer Society (ACS), the American Society for 
Colposcopy and Cervical Pathology (ASCCP), the American Society for Clinical Pathology and 
Screening (ASCPSG), and the American Congress of Obstetricians and Gynecologists (ACOG) 
recommend routine HPV screening be discontinued for average-risk women aged >65 years after 
three consecutive negative cytology results or two consecutive negative co-test results within the 
previous 10 years (CDC, 2017e; Elit, 2014; White et al., 2017). However, in 2014, of all new 
cervical cancers, 20% occurred in women 65 years old and older, and these women accounted for 
34% of the deaths related to cervical cancer (Elit, 2014). Although, the frequency of new HPV 
infections decline with age, women aged 25-55 remain at risk of obtaining an oncogenic HPV 
strain (Poppe et al., 2010). Therefore, age itself may need to be reconsidered, given high cervical 
cancer incidence rates, increases in life expectancy, and different human papillomavirus exposures 
by birth cohort (White et al., 2017).  
Research on the association between race/ethnicity, HPV screening, and age among United 
States women aged 18-64 is sparse. Many studies have demonstrated disparities in awareness of 
and knowledge about HPV among young, immigrant, and minority populations (Ford, 2011; Blake 
et al., 2015). Similarly, prior studies have investigated the perceptions, behaviors, and impact of 
ethnicity among adolescent and young women aged 15-25 regarding the HPV vaccination (Bond 
et al., 2016; Castellsague et al., 2009; Sadry et al., 2013). Yet, there is a lack of existing research 
that has investigated the role of race/ethnicity and HPV screening, and how it varies by age. 
Therefore, the purpose of this study is to assess the relationship between race/ethnicity and HPV 
screening, and to evaluate whether age modifies this association using population-based data from 
the Behavioral Risk Factor Surveillance System (BRFSS).   
 
METHODS 
Study Population and Design 
 This secondary data analysis used data from the 2016 Behavioral Risk Factor Surveillance 
System (BRFSS). This study protocol did not require approval by UNC Charlotte’s Institutional 
Review Board, given the study used publicly available, de-identified data. BRFSS is a large, 
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national survey initiated in 1984 by the Centers for Disease Control and Prevention (CDC) to target 
and build health promotion activities (CDC, 2014a). Detailed information on BRFSS methodology 
has been reported elsewhere (Lachan et al., 2016).  
 Briefly, the telephone-administered BRFSS survey collects information on more than 
400,000 adults each year (CDC, 2014a). The survey is conducted using Random Digit Dialing 
(RDD) techniques on both landlines and cell phones. Adults 18 years or older are asked to 
participate in the survey without monetary compensation (CDC, 2017a). The number of interviews 
within each state vary based on funding and the size of regions. In 2016, the average response rate 
for landline and cell phone samples were 46.7% (CDC, 2015).  
The questionnaire consists of three parts: (1) the core component, consisting of the fixed 
core, rotating core, and emerging core, (2) optional modules, and (3) state-added questions (CDC, 
2014a). BRFSS personnel are required to ask core component questions without modification in 
wording, however, the modules are optional (CDC, 2014a). The fixed core is a standard set of 
questions asked by all states that includes questions on demographic characteristics, plus current 
health behaviors. The rotating core is two distinct sets of questions, asked in alternating years by 
all states, addressing different topics; while, the emerging core is a set of five questions that are 
added to the fixed and rotating cores, focusing on prominent issues (CDC, 2014a). In 2012, the 
United States Preventive Services Task Force (USPSTF) recommendations included the HPV test 
for cervical cancer screening (CDC, 2014b). Thus, questions on HPV testing were included as a 
separate optional module on the 2014 BRFSS questionnaire and then added to the breast and 
cervical screening module the subsequent year (CDC, 2014b). Both questions about the Pap and 
HPV test were added to the core component of the questionnaire in 2016 to assess Pap and HPV 
screening.  
In 2016, 486,303 respondents provided BRFSS data (Figure 1). Men (n=210,606) and 
individuals who refused to disclose their gender (n=66) were excluded from this analysis. In 
addition, women who did not report their race/ethnicity (n=4,212), did not know if they ever had 
a HPV screening exam and/or refused to answer that question (n=75,871), and women who were 
65 or older and/or refused to disclose their age (n=74,902) were excluded from the analysis. Thus, 
120,646 women remained.  
Measurement of Race/Ethnicity  
 The main exposure was race/ethnicity. Participants self-reported their race/ethnicity, and it 
was categorized by BRFSS personnel as: ‘White only, Non-Hispanic’, ‘Black only, Non-
Hispanic’, ‘Other race only, Non-Hispanic’, ‘Multiracial, Non-Hispanic’, ‘Hispanic’ or ‘Don’t 
know/Not sure/Refused’. 
Measurement of HPV Screening  
 The main outcome was HPV screening. Participants were asked: “An HPV test is 
sometimes given with the Pap test for HPV screening. Have you ever had an HPV test?” (CDC, 
2017h). The response choices were ‘Yes’, ‘No’, ‘Don’t know/Not Sure’ or ‘Refused’. An answer 
of ‘yes’ meant the person did have the outcome (HPV test). If the participant answered, ‘don’t 
know/not sure’ or ‘refused’ then she was excluded.  
Measurement of Age 
 Participants were asked: “What is your age?” (CDC, 2014a). Participants self-reported their 
age, and it was categorized in five-year age categories (CDC, 2017h; Maldonado & Greenland, 
1993). These categories were: 18-24 years, 25-29 years, 30-34 years, 35-39 years, 40-44 years, 45-
49 years, 50-54 years, 55-59 years, 60-64 years, 65-69 years, 70-74 years, 75-79 years, 80 or older 
98  Does Age Affect the Association between Race/Ethnicity and HPV Screening 
Marlin and Brunner Huber 
 
Journal of Health Disparities Research and Practice Volume 12, Issue 3, Fall 2019 
 http://digitalscholarship.unlv.edu/jhdrp/    
Follow on Facebook:  Health.Disparities.Journal 
Follow on Twitter:  @jhdrp 
or ‘Don’t know/Refused/Missing’. If a participant answered 65 or older or refused to disclose her 
age then she was excluded.  
 
Figure 1. Exclusion Criteria for the Association Between Race/Ethnicity and HPV 




Measurement of Potential Confounding Factors 
 Based on a review of the literature, possible confounders of the race/ethnicity and HPV 
screening association include: healthcare coverage, education, income, marital status, and number 
of children in household (Ford et al., 2011; Blake et al., 2015). Information on these variables was 
self-reported by participants.  
Statistical Analysis 
 Frequencies and percentages were used to describe the study population. Logistic 
regression was used to obtain odds ratios (OR) and 95% confidence intervals (CIs) to provide an 
unadjusted measure of the association of race/ethnicity and HPV screening, and to identify other 
factors associated with HPV screening. Prior to constructing the multivariate model, collinearity 
diagnostics were considered to assess correlation between predictor variables, but no evidence of 
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multicollinearity was found (Kleinbaum et al., 1998; Hosmer et al., 2000). Multivariate logistic 
regression was used to calculate adjusted ORs and 95% CIs of the association between 
race/ethnicity and HPV screening, while controlling for potential confounders. If a potential 
confounding variable changed the magnitude of the OR estimate by at least 10%, it was considered 
a confounder of the association between race/ethnicity and HPV screening (Maldonado & 
Greenland, 1993). Ultimately, marital status, healthcare coverage, and income were confirmed as 
confounders in this analysis. A stratified analysis was conducted to determine if age modified the 
race/ethnicity and HPV screening association. A test of homogeneity was used to assess 
heterogeneity across strata.  Due to the complex sampling design used by BRFSS, SAS-callable 
SUDAAN was used in all analyses.  
  
RESULTS 
Demographic Characteristics of Study Population 
  Less than half of women reported having been screened for cervical cancer (46.67%). 
Most of the sample participants were between the ages of 18 and 39 years (50.24%), married 
(47.49%), reported an income of < $50,000 (46.07%), and had at least some college education 
(62.33%) (Table 1).  Most participants were non-Hispanic White (58.59%) followed by Hispanic 
(19.23%) and non-Hispanic Black (13.53%).  
Overall, the estimated HPV screening prevalence for all women was 35.9% (data not 
shown in table). HPV screening prevalence rates were highest for Multiracial women and lowest 
for non-Hispanic Other women (Multiracial:  45.5%, non-Hispanic Black:  39.4%, non-Hispanic 
White:  36.6%, Hispanic:  34.3%, and non-Hispanic Other:  26.3%). Further, HPV screening 
prevalence rates were highest among younger women who were 25-34 years of age (Ages: 18-24, 
28.2%; 25-29, 50.4%; 30-34, 50.6%; 35-39, 45.8%; 40-44, 40.4%; 45-49, 37.4%; 50-54, 29.6%; 
55-59, 25.0%; 60-64, 20.5%).  
 Women who reported being non-Hispanic Black (OR 1.10; 95% CI 1.02, 1.18) and 
Multiracial (OR 1.47; 95% CI 1.24, 1.73) had increased odds of HPV screening, while non-
Hispanic Other (OR 0.58; 95% CI 0.51, 0.65) and Hispanic women (OR 0.85; 95% CI 0.79, 0.91) 
had decreased odds of HPV screening as compared to non-Hispanic White women. In general, 
younger women had increased odds of HPV screening as compared to women aged 60-64, with 
the odds being highest among women aged 30-34 (OR 4.72; 95% CI 4.26, 5.24). Further, women 
who were never married had statistically significant decreased odds of HPV screening as compared 
to women who were married (OR 0.87; 95% CI 0.83, 0.92). Women without healthcare coverage 
had a 32% decreased odds of receiving HPV screening as compared to women who had healthcare 
coverage (OR 0.68; 95% CI 0.63, 0.73).  
Adjusted Association between Race/Ethnicity and HPV Screening  
 After adjustment for marital status, healthcare coverage, and income, the association 
between non-Hispanic Black and Multiracial race/ethnicity and HPV screening increased in 
magnitude and remained statistically significant (OR 1.20; 95% CI 1.11, 1.29 and OR 1.58; 95% 
CI 1.33, 1.88, respectively; Table 2). The association between non-Hispanic Other race/ethnicity 
and HPV screening remained unchanged after adjustment (OR 0.61; 95% CI 0.54, 0.69); while the 
association between Hispanic race/ethnicity and HPV screening was attenuated and no longer 
statistically significant (OR 1.02; 95% CI 0.95, 1.09). 
Adjusted Association between Race/Ethnicity and HPV Screening Stratified by Age  
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 The stratified analysis indicated age was an effect modifier of the race/ethnicity and HPV 
screening association (test for homogeneity p < 0.001; Table 3). In general, among younger women 
there were no clear associations between non-Hispanic Black or Multiracial race/ethnicity and 
HPV screening.  However, among the youngest categories of women, non-Hispanic Other and 
Hispanic race/ethnicity was associated with statistically significant decreased odds of HPV 
screening.  For example, among women 18-24 years of age, non-Hispanic Other women had nearly 
a 60% decreased odds of HPV screening as compared to non-Hispanic White women (OR 0.43; 
95% CI 0.31, 0.60) and Hispanic women had 22% decreased odds of HPV screening (OR 0.78; 
95% CI 0.64, 0.95). Among the oldest category of women (i.e. 60-64 years of age), there was no 
clear association between non-Hispanic Other race/ethnicity and HPV screening (OR 1.40; 95% 
CI 0.77, 2.57) while the other racial/ethnic groups had statistically significant increased odds of 
HPV screening. Specifically, in this oldest age group, non-Hispanic Black and Hispanic women 
had approximately 30% increased odds of HPV screening as compared to non-Hispanic White 
women (OR 1.29; 95% CI 1.05, 1.58 and OR 1.33; 95% CI 1.04, 1.71 respectively).  Among 
women in this age group, Multiracial women had over twice the odds of HPV screening (OR 2.16; 
95% CI 1.26, 3.71). 
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Table 1. Frequencies, Percentages, Unadjusted Odds Ratios, and 95% Confidence Intervals 




Abbreviations: BRFSS, Behavioral Risk Factor Surveillance System; N, Number. 
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Table 2. Adjusted Odds Ratios and 95% Confidence Intervals of the Association between 
Race/Ethnicity and HPV Screening; BRFSS 2016  
 
 
Abbreviations: BRFSS, Behavioral Risk Factor Surveillance System. 
1Adjusted for marital status, healthcare coverage, and income.  
 
 
Table 3. Adjusted Odds Ratios and 95% Confidence Intervals for the Association between 
Race/Ethnicity and HPV Screening Stratified by Age; BRFSS 2016 
 
Abbreviations: BRFSS, Behavioral Risk Factor Surveillance System. 
1Adjusted for marital status, healthcare coverage, and income. Test of homogeneity: p < 0.001 
 
DISCUSSION 
 In this population-based study of United States women, women who reported being non-
Hispanic Black and Multiracial had statistically significant increased odds of HPV screening; 
while, non-Hispanic Other women had decreased odds of HPV screening as compared to non-
Hispanic White women. There was no association between the Hispanic race/ethnicity and HPV 
screening.  In addition, age was determined to be an effect modifier of the association between 
race/ethnicity and HPV screening.  
 Most findings remain consistent among United States women, although existing literature 
demonstrates that HPV testing as cervical cancer screening have been examined on a greater 
magnitude than the conventional Pap test. Previous literature examining race/ethnicity and cervical 
cancer screening as conventional Pap testing have been consistent with our findings in that non-
Hispanic Black and non-Hispanic White women are noted to have the highest cervical cancer 
screening rates among ethnic groups compared to Hispanic and non-Hispanic Other women (Akers 
et al., 2007). However, other findings related to the Hispanic race/ethnicity and Pap test screening 
have been inconsistent. One study of United States women (n= 4,992) found the Hispanic 
race/ethnicity was associated with an increased odds of Pap test screening, but this finding was not 
statistically significant (OR 1.36; 95% CI 0.85, 2.20) (Hirth et al., 2016). Conversely, a larger 
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study (n=272,692) found Hispanic women had statistically significant decreased odds of HPV test 
screening (OR 0.54; 95% CI 0.50, 0.60) (CDC, 2017c). In our study, there was no association 
between the Hispanic race/ethnicity and HPV screening. The inconsistency among the Hispanic 
race/ethnicity and HPV screening may be attributable to the variation in sample sizes in previous 
studies.  
 To our knowledge, no other study has examined age as an effect modifier of the association 
between race/ethnicity and HPV screening. In our study, age modified the association between 
race/ethnicity and HPV screening. Among the oldest categories of women, non-Hispanic Black, 
Multiracial, and Hispanic women had increased odds of HPV screening. Other trends varied by 
ethnic subgroup. In general, non-Hispanic Other women had decreased odds of HPV screening, 
where almost all age groups were statistically significant. Conversely, Multiracial women had 
increased odds of HPV screening although findings were not statistically significant among all age 
groups.  
 Studies regarding age, race/ethnicity, Pap and HPV test screening have been conflicting. 
One study found young women had increased Pap test screening, and this was similar across all 
ethnic groups (Akers et al., 2007).  Another study that used BRFSS data found being between the 
ages 18-44, non-Hispanic White, Hispanic, and non-Hispanic Other race/ethnicity decreased the 
odds of HPV test screening (CDC, 2017c). However, both studies did not evaluate age as an effect 
modifier. Our findings are similar to the previous study, where young non-Hispanic Other and 
Hispanic women had a decreased odds of HPV screening as compared to non-Hispanic White 
women within the same age group. This may indicate these women have low health literacy and/or 
lack sexual health knowledge (Bond et al., 2016; Akers et al., 2007). Specifically, among Hispanic 
women, where another study found this ethnic group lacked sexual health knowledge in methods 
to prevent cervical cancer (Bond et al., 2016). 
Further, another study found that being between the ages of 45-74 increased the odds of 
HPV test screening after adjustment for demographic and socioeconomic factors (CDC, 2017c). 
While, another study demonstrated that the association between older age and Pap test screening 
did not differ significantly by race/ethnicity (Hirth et al., 2016). Our research is inconsistent with 
these previous findings, in that among women aged 60-64, non-Hispanic Black, Multiracial, and 
Hispanic ethnic groups had increased odds of being screened for cervical cancer by HPV testing. 
It is important to note that while these previous studies investigated similar associations to our 
study, none of them considered whether the race/ethnicity-HPV screening association differed by 
age.  Regardless, our findings may indicate that older women are more likely to be screened for 
cervical cancer due to regularly scheduled healthcare visits from treating other chronic health 
conditions (Miles-Richardson et al., 2017). 
 This study has several limitations. Since the exposure and outcome variables were self-
reported, misclassification is possible. While participants likely were able to self-report 
race/ethnicity, they may have had problems remembering or comprehending if they ever had an 
HPV test as this question covers an unspecified timeframe that might be erroneously linked to 
another disease or condition. Furthermore, some evidence suggests that certain racial/ethnic groups 
may be less likely to provide accurate reports of their cancer screening behavior (Burgess et al., 
2008; Cronin et al., 2009). Thus, non-differential and differential misclassification of the outcome 
is possible. Bias by indication may have occurred as the outcome may have been confounded by 
whether it was part of a woman’s routine healthcare screening or as a diagnostic after an abnormal 
Pap test. Furthermore, this study was limited to the questions asked on the BRFSS survey and also 
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subject to residual confounding as income values were reported missing. Thus, confounding due 
to known or unknown variables is possible. Selection bias is likely due to the response rate for the 
year of data used was 46.7% (CDC, 2015). Furthermore, many women indicated that they were 
unaware if they ever had HPV screening and were thus excluded from the analysis.  We evaluated 
whether eligible women differed from ineligible women with respect to sociodemographic factors.  
Eligible women did differ from ineligible women with respect to income, education level, and 
marital status.  Specifically, eligible women were in the highest income group, never married, and 
had at least some college education. Thus, the possibility of bias cannot be ruled out.  
This study also had several strengths. While information bias cannot be ruled out, it is 
limited due to the highly trained BRFSS interviewers. Also, generalizability may be limited to 
some sample sizes since the BRFSS sampled from a large population base within the United States. 
Moreover, this study examined how age modified the race/ethnicity-HPV screening association 
among United States women, which has not been evaluated in previous research. 
 
CONCLUSION 
 Findings from this study provides evidence that age does modify the association between 
race/ethnicity and HPV screening among women 18 years of age and older in the U.S. This study 
highlights the need to target non-Hispanic Other and Hispanic women to increase use of HPV test 
screening. Public health interventions and health care providers may need to focus on specific 
minority subgroups to increase HPV screening in certain sub age categories. Given the limited 
research on this topic, future studies should further examine the association between race/ethnicity, 
HPV screening, and age among a diverse population of women.  
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